NEWS News Release：Press Release

U-Factor® Solution Yields Groundbreaking miRNA Marker for Therapeutic Effect

Commencement of Joint Research with Tokyo Jikei University School of Medicine

Yuji Teramura has been selected to receive the 2024 Japan Society for Biomaterials Award (Science).

Discovery of Components with the Same Effects as Stem Cell Transplantation from Immortalized Stem Cell-Derived Substances

U-Factor Co., Ltd., a Drug Discovery Venture Focused on Developing Therapeutics Using Stem Cell Culture Supernatant, Launches Second Phase of Ophthalmic Disease Research in Collaboration with Keio University School of Medicine

U-Factor Co., Ltd. Signs Joint Research Agreement with Tokyo Women’s Medical University for the Development of Therapeutics Using U-Factor solution

Announcement of the Commencement of a Specific Clinical Study for ALS

U-Factor Co., Ltd. Signs Agreement with AIST Solutions

Filed a patent for a dry eye treatment in collaboration with Keio University

We have invented a new culture supernatant in collaboration with AIST